Evaluation of the Effect of AZD5069 in Patients With Bronchiectasis

Status:
Completed

Trial end date:
2012-02-01

Target enrollment:

Participant gender:

The purpose of this study is to investigate the effect of AZD5069 in patients with bronchiectasis.

Phase 2

AstraZeneca